NEXGARD 1 (2-4 KG) (NARANJA)
Antiparasitario: Afoxolaner |
NEXGARD (2-4 KG)
Tratamiento y prevención de infestación por: pulgas, garrapatas, sarna demodéctica, sarna sarcóptica, sarna otodéctica y miasis.
COMPONENETES:
![](data:image/png;base64,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)
DOSIS:
Vía oral 1 tableta masticable una vez por mes.
Puede administrarse con o sin comida sin alterar su eficacia.
Para cachorros a partir de los 2 meses de edad y con un peso mínimo de 2 kg.
CONTRAINDICACIONES:
En perros que presenten historial de convulsiones.
GESTACIÓN Y LACTANCIA:
No se han realizado estudios con Nexgard en perras gestantes o lactantes, sin embargo ha demostrado tener un excelente perfil de seguridad en animales de laboratorio.
Su fragmento dinámico se mostrará aquí...
Este mensaje se muestra porque no proporcionó un filtro y una plantilla para usar.